Company TapImmune Inc. OTC Bulletin Board
Equities
US8760332002
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
05-15 | Marker Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-10-31 |
Chief Tech/Sci/R&D Officer | 51 | 18-10-22 | |
Chief Administrative Officer | - | 15-08-31 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 20-12-31 |
Nadia Agopyan
LAW | General Counsel | 62 | 19-08-14 |
General Counsel | 67 | 18-10-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 18-10-16 |
Steven Elms
BRD | Director/Board Member | 60 | 19-08-05 |
Katharine Knobil
BRD | Director/Board Member | 60 | 21-12-07 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,919,095 | 7,830,643 ( 87.80 %) | 0 | 87.80 % |
Company contact information
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+40.83% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- MRKR Stock
- Stock
- Company TapImmune Inc.